Friday, May 03, 2019 7:55:50 AM
NEWS PROVIDED BY
Alzheimer Society of Canada
Mar 20, 2019, 11:12 ET
A significant milestone for Canadians living with dementia and their families
TORONTO, March 20, 2019 /CNW/ - The Alzheimer Society of Canada is pleased that the Federal budget released on Tuesday, March 19 will provide $50 million over five years to fund Canada's first national dementia strategy.
Starting this year, the Government of Canada will invest in increased public awareness of dementia through targeted campaigns and activities with a focus on risk reduction, prevention, and combatting the stigma associated with the disease. Investments will also be made in developing treatment guidelines and best practices to promote early diagnosis in cooperation with provincial and territorial partners, as well as understanding the impact of dementia on Canadian communities.
"This investment is great news and we look forward to more robust initiatives as our government builds and implements the national dementia strategy," says Pauline Tardif, CEO at the Alzheimer Society of Canada and Co-chair of the Ministerial Advisory Board on Dementia.
The Alzheimer Society has long advocated for a national dementia strategy and has been working closely with the Minister of Health and the Public Health Agency of Canada in informing the strategy, expected to be announced this spring.
"Our goal ultimately is to see a fully funded and comprehensive national dementia strategy so that Canadian families are well positioned to live as best as possible with dementia, from the point of diagnosis to the end of life," adds Tardif. "This important budget investment is a significant step toward this."
About the Alzheimer Society
The Alzheimer Society is Canada's leading nationwide health charity for people living with Alzheimer's disease and other dementias. Active in communities across Canada, the Society provides information, programs and services, and raises funds for research to better understand the causes of dementia, improve treatment and care, and to find cures.
Quick facts
Today, over half a million Canadians are living with dementia.
In less than 15 years, this number will nearly double to almost a million.
Women over the age of 65 account for 65 per cent of all Canadians living with dementia.
For every person with dementia, there are one or more family members who provide care.
Canadians spend over $10.4 billion each year in direct and indirect costs to care for those with dementia. This number is expected to jump to $16.6 billion in less than 15 years.
In 2011 alone, caregivers devoted 19.2 million hours of unpaid care, representing a value of $1.2 billion
On average, costs for people with dementia are about five-and-a-half times greater than for those without the condition. Home care and long-term care are the largest contributors to direct care.
Download our 2019 pre-budget submission: https://alzheimer.ca/sites/default/files/files/national/advocacy/asc_pre-budget-submission.pdf
SOURCE Alzheimer Society of Canada
For further information: Media contact: Rosanne Meandro, Director of Communications, Direct: 416-847-8920, Mobile: 416-669-5715, rmeandro@alzheimer.ca, www.alzheimer.ca
Related Links
www.alzheimer.ca
https://www.newswire.ca/news-releases/alzheimer-society-welcomes-50-million-funding-for-national-dementia-strategy-802554998.html
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM